These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7827407)

  • 21. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.
    Miao HQ; Ishai-Michaeli R; Peretz T; Vlodavsky I
    J Cell Physiol; 1995 Sep; 164(3):482-90. PubMed ID: 7650058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin inhibits the binding of basic fibroblast growth factor to cultured human aortic smooth-muscle cells.
    Bono F; Rigon P; Lamarche I; Savi P; Salel V; Herbert JM
    Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):661-8. PubMed ID: 9307014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor.
    Maccarana M; Casu B; Lindahl U
    J Biol Chem; 1993 Nov; 268(32):23898-905. PubMed ID: 8226930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions.
    Klagsbrun M
    Semin Cancer Biol; 1992 Apr; 3(2):81-7. PubMed ID: 1378313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimum FGF2 binding structural requirements of heparin and heparan sulfate oligosaccharides as determined by NMR spectroscopy.
    Guglier S; Hricovíni M; Raman R; Polito L; Torri G; Casu B; Sasisekharan R; Guerrini M
    Biochemistry; 2008 Dec; 47(52):13862-9. PubMed ID: 19117094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells.
    Ornitz DM; Yayon A; Flanagan JG; Svahn CM; Levi E; Leder P
    Mol Cell Biol; 1992 Jan; 12(1):240-7. PubMed ID: 1309590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF receptors.
    Rusnati M; Urbinati C; Presta M
    J Cell Physiol; 1993 Jan; 154(1):152-61. PubMed ID: 8419401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural features in heparin that interact with VEGF165 and modulate its biological activity.
    Ono K; Hattori H; Takeshita S; Kurita A; Ishihara M
    Glycobiology; 1999 Jul; 9(7):705-11. PubMed ID: 10362840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain.
    Thompson LD; Pantoliano MW; Springer BA
    Biochemistry; 1994 Apr; 33(13):3831-40. PubMed ID: 8142385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specificities of heparin-binding sites from the amino-terminus and type 1 repeats of thrombospondin-1.
    Yu H; Tyrrell D; Cashel J; Guo NH; Vogel T; Sipes JM; Lam L; Fillit HM; Hartman J; Mendelovitz S; Panel A; Roberts DD
    Arch Biochem Biophys; 2000 Feb; 374(1):13-23. PubMed ID: 10640391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural studies of octasaccharides derived from the low-sulfated repeating disaccharide region and octasaccharide serines derived from the protein linkage region of porcine intestinal heparin.
    Yamada S; Sakamoto K; Tsuda H; Yoshida K; Sugiura M; Sugahara K
    Biochemistry; 1999 Jan; 38(2):838-47. PubMed ID: 9888825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin-derived oligosaccharides: affinity for acidic fibroblast growth factor and effect on its growth-promoting activity for human endothelial cells.
    Bârzu T; Lormeau JC; Petitou M; Michelson S; Choay J
    J Cell Physiol; 1989 Sep; 140(3):538-48. PubMed ID: 2550475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Capillary electrophoresis and enzyme solid phase assay for examining the purity of a synthetic heparin proteoglycan-like conjugate and identifying binding to basic fibroblast growth factor.
    Dimitrellos V; Lamari FN; Militsopoulou M; Kanakis I; Karamanos NK
    Biomed Chromatogr; 2003 Jan; 17(1):42-7. PubMed ID: 12583005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization of Xenopus embryo heparan sulfate. Differential structural requirements for the specific binding to basic fibroblast growth factor and follistatin.
    Yamane Y; Tohno-oka R; Yamada S; Furuya S; Shiokawa K; Hirabayashi Y; Sugino H; Sugahara K
    J Biol Chem; 1998 Mar; 273(13):7375-81. PubMed ID: 9516434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diminished heparin binding of a basic fibroblast growth factor mutant is associated with reduced receptor binding, mitogenesis, plasminogen activator induction, and in vitro angiogenesis.
    Li LY; Safran M; Aviezer D; Böhlen P; Seddon AP; Yayon A
    Biochemistry; 1994 Sep; 33(36):10999-1007. PubMed ID: 7522051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequence analysis of heparan sulphate and heparin oligosaccharides.
    Vivès RR; Pye DA; Salmivirta M; Hopwood JJ; Lindahl U; Gallagher JT
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):767-73. PubMed ID: 10215618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basic fibroblast growth factor does not prevent heparan sulphate proteoglycan catabolism in intact cells, but it alters the distribution of the glycosaminoglycan degradation products.
    Tumova S; Hatch BA; Law DJ; Bame KJ
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):471-81. PubMed ID: 9895290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycosaminoglycans can influence fibroblast growth factor-2 mitogenicity without significant growth factor binding.
    Wang H; Toida T; Kim YS; Capila I; Hileman RE; Bernfield M; Linhardt RJ
    Biochem Biophys Res Commun; 1997 Jun; 235(2):369-73. PubMed ID: 9199199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
    Krufka A; Guimond S; Rapraeger AC
    Biochemistry; 1996 Aug; 35(34):11131-41. PubMed ID: 8780517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oligomerization reduces heparin affinity but enhances receptor binding of fibroblast growth factor 2.
    Safran M; Eisenstein M; Aviezer D; Yayon A
    Biochem J; 2000 Jan; 345 Pt 1(Pt 1):107-13. PubMed ID: 10600645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.